Shopping Cart

Remove All
Your shopping cart is currently empty

TMN355

TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis.

Catalog No. T13171Cas No. 1186372-20-2

Select Batch

Purity:99.15%

Resource Download

COA LCMS HNMR HPLC

TMN355

Catalog No. T13171Cas No. 1186372-20-2

TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability
1 mg	$35	In Stock
2 mg	$50	In Stock
5 mg	$81	In Stock
10 mg	$123	In Stock
25 mg	$247	In Stock
50 mg	$372	In Stock
100 mg	$548	In Stock
500 mg	$1,170	In Stock
1 mL x 10 mM (in DMSO)	$89	In Stock

Bulk & Custom

Add to Cart

Questions

Related Compound Libraries of "TMN355"

Product Introduction

Bioactivity

Description

TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis.

In vitro

Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL. The expression of scavenger receptors expressed during differentiation process, CD36 and LOX-1 were decreased (p < 0.0001). Levels of extracellular cyclophilin A and other inflammatory cytokines such as TNF-α and MCP-1also significantly reduced. TMN 355 (0.5-10 μM; 3-9 hours) results in 75.9% reduction of cyclophilin A protein expression. And cyclophilin A after 6 h of activation inhibited by TMN 355(1 μM).

Chemical Properties

Molecular Weight	380.8
Formula	C₂₁H₁₄ClFN₂O₂
Cas No.	1186372-20-2

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Solubility Information

DMSO: 40 mg/mL (105.04 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.6261 mL	13.1303 mL	26.2605 mL	131.3025 mL
5 mM	0.5252 mL	2.6261 mL	5.2521 mL	26.2605 mL
10 mM	0.2626 mL	1.3130 mL	2.6261 mL	13.1303 mL
20 mM	0.1313 mL	0.6565 mL	1.3130 mL	6.5651 mL
50 mM	0.0525 mL	0.2626 mL	0.5252 mL	2.6261 mL
100 mM	0.0263 mL	0.1313 mL	0.2626 mL	1.3130 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

InhibitorinhibitTMN-355TMN 355TMN355